Alps Advisors Inc Travere Therapeutics, Inc. Transaction History

Alps Advisors Inc

$14.1 Billion
Q1 2024

A detailed history of Alps Advisors Inc transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 53,672 shares of TVTX stock, worth $426,155. This represents 0.0% of its overall portfolio holdings.

Number of Shares

53,672

Previous 47,055 14.06%

Holding current value

$426,155

Previous $423,000 2.36%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$7.18 - $9.82 $47,510 - $64,978	6,617 Added 14.06%	53,672 $413,000
Q4 2023 Feb 14, 2024	SELL	$5.44 - $9.5 $45,255 - $79,030	-8,319 Reduced 15.02%	47,055 $423,000
Q3 2023 Nov 14, 2023	BUY	$7.64 - $17.25 $4,056 - $9,159	531 Added 0.97%	55,374 $495,000
Q2 2023 Aug 14, 2023	BUY	$15.3 - $22.61 $102,984 - $152,187	6,731 Added 13.99%	54,843 $842,000
Q1 2023 May 10, 2023	BUY	$17.82 - $22.89 $82,185 - $105,568	4,612 Added 10.6%	48,112 $1.08 Million

Q4 2022 Feb 14, 2023	BUY	$18.47 - $26.14 $158,601 - $224,464	8,587 Added 24.6%	43,500 $914,000
Q3 2022 Nov 14, 2022	SELL	$22.91 - $28.63 $63,369 - $79,190	-2,766 Reduced 7.34%	34,913 $860,000
Q2 2022 Aug 11, 2022	SELL	$20.94 - $30.01 $577,441 - $827,555	-27,576 Reduced 42.26%	37,679 $913,000
Q1 2022 May 16, 2022	SELL	$23.61 - $30.6 $132,192 - $171,329	-5,599 Reduced 7.9%	65,255 $1.68 Million
Q4 2021 Feb 09, 2022	SELL	$24.34 - $31.17 $86,577 - $110,871	-3,557 Reduced 4.78%	70,854 $2.2 Million
Q3 2021 Nov 15, 2021	SELL	$12.98 - $25.03 $67,677 - $130,506	-5,214 Reduced 6.55%	74,411 $1.8 Million
Q2 2021 Aug 11, 2021	SELL	$14.11 - $26.4 $414,128 - $774,840	-29,350 Reduced 26.93%	79,625 $1.16 Million
Q1 2021 May 07, 2021	BUY	$23.37 - $31.77 $396,425 - $538,914	16,963 Added 18.44%	108,975 $2.72 Million
Q4 2020 Feb 03, 2021	BUY	$19.17 - $27.87 $1.76 Million - $2.56 Million	92,012 New	92,012 $2.51 Million

Others Institutions Holding TVTX

# of Institutions

184

Shares Held

89.5M

Call Options Held

66.9K

Put Options Held

265K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $510M
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Travere Therapeutics, Inc. Transaction History